OpenLB
Open Library of Bioscience
Advanced Search
PharmacoEconomics
11, 2019;37 (11): 1303-1304.

Improving Transparency in Decision Models: Current Issues and Potential Solutions.

Paul Tappenden, J Jaime Caro
Author Information
  1. Paul Tappenden: HEDS, ScHARR, University of Sheffield, Sheffield, UK.
  2. J Jaime Caro: Department of Health Policy, The London School of Economics and Political Science, London, UK. Jaime.caro@mcgill.ca. ORCID
PMID: 31642021 DOI: 10.1007/s40273-019-00850-0

Abstract

No abstract text available.

References

  1. Pharmacoeconomics. 2019 Nov;37(11):1305-1312 [PMID: 31347104]
  2. Pharmacoeconomics. 2019 Nov;37(11):1355-1369 [PMID: 31240636]
  3. Pharmacoeconomics. 2019 Nov;37(11):1409-1410 [PMID: 31065916]
  4. Pharmacoeconomics. 2019 Nov;37(11):1321-1327 [PMID: 31485925]
  5. Pharmacoeconomics. 2019 Nov;37(11):1329-1339 [PMID: 31549359]
  6. Pharmacoeconomics. 2019 Nov;37(11):1391-1408 [PMID: 31705406]
  7. Pharmacoeconomics. 2019 Nov;37(11):1349-1354 [PMID: 31591672]
  8. Pharmacoeconomics. 2019 Nov;37(11):1313-1320 [PMID: 31392665]
  9. Pharmacoeconomics. 2019 Nov;37(11):1341-1347 [PMID: 31544217]
  10. Pharmacoeconomics. 2019 Nov;37(11):1383-1390 [PMID: 31250397]
  11. Pharmacoeconomics. 2019 Nov;37(11):1371-1381 [PMID: 31531833]

MeSH Term

Decision Making
Decision Support Techniques
Humans
Technology Assessment, Biomedical
Editorial Introductory Journal Article
Article has an altmetric score of 1

Word Cloud

Created with Highcharts 10.0.0ImprovingTransparencyDecisionModels:CurrentIssuesPotentialSolutions

Similar Articles

Cited By